CONVATEC GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 282.6 GBX | -0.35% |
|
-0.07% | +15.72% |
| Apr. 15 | Convatec Launches New Esteem Body with Leak Defense | CI |
| Apr. 04 | Moody's Lifts Convatec's Ratings on Strong Organic Growth, Product Diversification | MT |
Financials (USD)
| Sales 2024 * | 2.27B | Sales 2025 * | 2.41B | Capitalization | 7.18B |
|---|---|---|---|---|---|
| Net income 2024 * | 195M | Net income 2025 * | 248M | EV / Sales 2024 * | 3.64 x |
| Net Debt 2024 * | 1.08B | Net Debt 2025 * | 888M | EV / Sales 2025 * | 3.35 x |
| P/E ratio 2024 * |
36.6
x | P/E ratio 2025 * |
28.5
x | Employees | 10,136 |
| Yield 2024 * |
1.84% | Yield 2025 * |
2% | Free-Float | 79.88% |
More Fundamentals
* Assessed data
More news
Latest transcript on ConvaTec Group Plc
More recommendations
More press releases
More news
| 1 day | -0.35% | ||
| 1 week | -0.07% | ||
| Current month | -1.33% | ||
| 1 month | -1.12% | ||
| 3 months | +15.35% | ||
| 6 months | +44.04% | ||
| Current year | +15.72% |
1 week
277.60
285.80
1 month
277.60295.20
Current year
232.40295.20
1 year
195.10295.20
3 years
165.30295.20
5 years
130.45295.20
10 years
113.25349.10
| Managers | Title | Age | Since |
|---|---|---|---|
Karim Bitar
CEO | Chief Executive Officer | 59 | 19-09-29 |
Jonathan Mason
DFI | Director of Finance/CFO | 60 | 22-01-30 |
John Haller
COO | Chief Operating Officer | - | 22-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kimberly Lody
BRD | Director/Board Member | 58 | 22-01-31 |
John McAdam
CHM | Chairman | 76 | 19-09-29 |
Margaret Ewing
BRD | Director/Board Member | 69 | 17-08-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.22% | 182 M€ | +3.17% | ||
| 0.14% | 1,120 M€ | -1.50% | ||
| 0.07% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 282.6 | -0.35% | 4,198,443 |
| 24-04-18 | 283.6 | +0.93% | 4,539,271 |
| 24-04-17 | 281 | -0.64% | 4,030,806 |
| 24-04-16 | 282.8 | -0.42% | 4,022,505 |
| 24-04-15 | 284 | +0.42% | 6,578,921 |
Delayed Quote London S.E., April 19, 2024 at 11:35 am EDT
More quotes
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, incontinence and critical care. The group also offers perfusion devices. Net sales break down by area of activity as follows:
- wound care (29.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.;
- incontinence and critical care (26.4%);
- ostomy care (25.2%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.;
- infusion (18.5%).
At the end of 2022, the group operated 9 production sites worldwide.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (33.2%), Americas (52.6%) and Asia/Pacific (14.2%).
Calendar
2024-05-15
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
3.508
USD
Average target price
3.962
USD
Spread / Average Target
+12.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.72% | 7.18B | |
| -2.53% | 186B | |
| -3.52% | 106B | |
| +5.33% | 50.39B | |
| +16.43% | 47.65B | |
| -1.73% | 39.29B | |
| +5.66% | 27.24B | |
| -2.01% | 25.42B | |
| +9.84% | 24.39B | |
| -1.87% | 24.54B |
- Stock Market
- Equities
- CTEC Stock
